IMUNA PHARM, a.s

Flebogamma

Flebogamma® DIF 100 mg/ml*

Pharmacotherapeutic group:

Immune sera and immunoglobulins: immunoglobulins, normal human, for intravascular administration (ATC code: J06BA02)

Characteristics

One ml contains 100 mg of normal human immunoglobulin obtained from human plasma pools (*donors from the Slovak Republic). It is indicated as substitution therapy in adults, children and adolescents (2-18 years of age): Primary immunodeficiency syndrome with reduced antibody production.Hypogammaglob-ulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia who have previously failed prophylactic antibiotic therapy. Hypogamaglobulinaemia and recurrent bacterial infections in patients with multiple myeloma who have failed to respond to pneumococcal immunisation. Hypogammaglobulinaemia in HSCT patients (hematopoietic stem cell transplantation). Congenital AIDS with recurrent bacterial infections. Immunomodulation in adults, children and adolescents (2-18 years): Idiopatic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count. Guillain-Barré syndrome. Kawasaki disease.